Navigation Links
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
Date:5/3/2009

MARSEILLE, France, May 4 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, the manufacturing and the commercialization of diagnostic assays for breast cancer and leukemia, today announces the signature of an agreement with ARUP Laboratories to offer JAK2 molecular diagnostic testing in the USA.

According to the terms of the agreement, Ipsogen grants ARUP, a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development, non-exclusive rights, for the US territory, to offer a complete range of assays for the molecular classification and the screening of Myeloproliferative Neoplasms (MPN), a group of leukaemia's caused by JAK2 gene variations that affects more than 100,000 people in the US. Additional terms were not disclosed.

"This agreement with ARUP, reinforces the medical value of the JAK2 test as a diagnostic tool for MPN supported by the World Health Organization (WHO) guidelines and affirms the strong Intellectual Property position of Ipsogen's JAK2 patent portfolio," said Vincent Fert, Chairman and CEO of Ipsogen.

"We are pleased to have ARUP enter into our licensing program. This agreement supports our strategy to fully supply the US JAK2 market through a combination of strategic licensing arrangements and product sales to leading cancer institutions, hospitals, and commercial labs," added Susan Hertzberg, President of Ipsogen Inc.

JAK2 V617F mutation

In 2006, Ipsogen concluded a worldwide exclusive licensing agreement following the discovery of JAK2 V617F by the INSERM team of Dr. Vainchenker at Institut Gustave Roussy, Paris, France. This team identified the key role played by this mutation of the JAK2 gene in the development of MPN such as Vaquez disease (Polycythemia Vera), Idiopathic Myelofibrose or
'/>"/>

SOURCE Ipsogen SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
2. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
3. Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
4. Premier Research Expands its Medical Device Operations to the United States
5. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
6. Myeloperoxidase Research Expands
7. IBT Laboratories Expands its Menu of Tests for Immune Deficiency
8. Micromet Expands Committed Equity Financing Facility to $75 Million
9. Evalve Expands Executive Leadership Team
10. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
11. Particle Sciences Expands Its Combination Product Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
(Date:2/26/2015)... Mass. , Feb. 26, 2015  Spring ... novel therapeutics for the treatment of Hepatitis B ... the closing of a $22 million financing. Funds ... SB 9200, a novel, broad spectrum antiviral agent ... nucleic acid hybrid (SMNH) chemistry platform, into Phase ...
(Date:2/26/2015)... 26, 2015 The market for IVD ... is estimated at 2.4 billion in 2014.   The ... government insurance, newly insured patients and updated healthcare ... will continue to propel demand.  The healthcare market research ... market and interviews with IVD manufacturers and distributors.  ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4
... MedAxiom, a subscription-based service provider and information resource ... today announced a significant expansion to its Corporate Partner ... Anodyne Health, have joined the program so far this ... cardiology practice members.  MedAxiom now has more than 30 ...
... 27, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
Cached Medicine Technology:Anodyne Health, Seven Other Companies Join in Significant Expansion of MedAxiom Corporate Partner Program 2Anodyne Health, Seven Other Companies Join in Significant Expansion of MedAxiom Corporate Partner Program 3Anodyne Health, Seven Other Companies Join in Significant Expansion of MedAxiom Corporate Partner Program 4Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 2Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 3Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 4Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 5Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 6Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene 7
(Date:2/27/2015)... 27, 2015 Many mattresses contain ... health. Mercola.com has introduced organic cotton mattresses and ... flame retardant chemicals. Dr. Mercola’s Healthy Home mattresses ... better materials. Organic cotton is significantly less flammable ... bedding products are made by Naturepedic and are ...
(Date:2/27/2015)... ResearchMoz has announced the addition ... of the cell culture protein surface coating market ... current scenario and development prospects of the global ... period of 2015 to 2019. , Read Complete ... The research report, titled Global Cell Culture Protein ...
(Date:2/27/2015)... Summit County, CO (PRWEB) February 27, 2015 ... Kevin and Amy Smits help to restore ... year for the last six years, this husband/wife Realtor team ... of the charities have remained the same while others have ... Victims of Assault provides a safe haven and counseling ...
(Date:2/27/2015)... February 27, 2015 Qualis Health, ... organizations, has been named a finalist in the ... recognition of outstanding commitment toward continuous improvement in ... in reducing hospital readmission rates through its Communities ... are honored to receive this national recognition, which ...
(Date:2/27/2015)... 2015 Jvion announced today that ... with the Atlanta-based software company through a strategic ... advanced predictive capabilities suite within the provider market. ... and prevents financial and clinical losses within hospitals. ... help prevent patient deterioration and suffering, the support ...
Breaking Medicine News(10 mins):Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 2Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3
... young children with bottles of fruit juice and sugary drinks, ... Australia. ,Many children turn up requiring as many as ... ,In the most severe cases, pediatric dentists are being left ... ,"It's a tragedy when we see this, but it's ...
... ago there was a theory doing the rounds that the ... individual. This theory was not well received and was ... the proponents of the theory to associate the schemingly silent ... ,Autism is a developmental disability that affects the ...
... is finally on the way for 70-year-old Hakimuddin of ... district administration promising assistance after the impoverished man ... lives. ,The district collector of Bhadrak in ... to conduct an inquiry on the condition of the ...
... is linked to a substantial increase in risk for heart ... findings are published today in the online edition of Science, ... journal. ,Researchers found individuals with the variation have ... infarction) and a 2.02-fold greater risk of suffering a heart ...
... a liver transplant is highly accurate in showing vascular ... recent study. ,The study consisted of 39 ... developing fluid in the abdomen and/or unclear liver function ... in the early post transplant period, caused by acute ...
... to know what makes certain babies prone to SIDS ... the Royal Hospital for Sick Children in Glasgow have closed ... babies which expose them to risks of cot death. ... and child health sciences division, are team leaders of a ...
Cached Medicine News:Health News:Experts Call for Warning Lables on Fruit Juice to Save Kids' Teeth 2Health News:Diet for Autism 2Health News:Diet for Autism 3Health News:Disabled Orissa Brothers Lives Saved by Timely Intervention 2Health News:Genetic Variation is Linked to Substantial Risk in Heart Attack 2
Flexible rake retractor, 3 blunt prongs....
Rees bayonet forceps, standard, 5-1/2", TC....
... Implants, designed to accept rigid ... with an excellent reconstructive option ... floor blowout defects. Each design ... of one or more rigid ...
... Medpor Midface Rim is designed ... concavities of the midface, including ... malar. When positioned in the ... Medpor Midface Rim implant aids ...
Medicine Products: